Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

COVID-19 2Urinary Bladder Neoplasms 1Testicular Neoplasms 1

Interventions

Surveys and Questionnaires 286Blood Specimen Collection 145Gene Expression Profiling 96Interviews as Topic 83Immunohistochemistry 78Polymerase Chain Reaction 64Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 58Microarray Analysis 55Flow Cytometry 53Radiotherapy 49Amplified Fragment Length Polymorphism Analysis 48Drug Therapy 46Observation 45Biopsy 42Reverse Transcriptase Polymerase Chain Reaction 39Bevacizumab 39Data Collection 35Sorafenib 29Psychiatric Rehabilitation 29Nivolumab 28palbociclib 26In Situ Hybridization, Fluorescence 26Rituximab 25Therapeutics 24Neoadjuvant Therapy 24Hepatectomy 24Docetaxel 24Colonoscopy 24Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Observational × Pandemic Preparedness × Clear all
NCT05083143 2022-04-27

The Impact of the COVID-19 Pandemic on Testicular Cancer

Ankara Training and Research Hospital

Completed
50 enrolled
Genitourinary

COVID-19, Testicular Neoplasms

NCT04900259 2021-10-06

The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations

Ankara Training and Research Hospital

Completed
183 enrolled
Genitourinary

COVID-19, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡